News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

STC Life Co., Ltd Successfully Treats Canadian Pulmonary Fibrosis Patient At 97.7 B&H Hospital Stem Cell Center



3/12/2014 8:48:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SEOUL, South Korea--(BUSINESS WIRE)--Stem cell research institute of STC Life Co., Ltd. (Chairman: KYE HO LEE) and 97.7 B&H Clinic (Representative Doctor: WON JU JUNG) successfully finished mesenchymal stem cell therapy for the pulmonary fibrosis patient who visited Korea from Calgary, Canada. Pulmonary fibrosis is a disease caused by overproduction of fibrous tissues while lung tissues are consistently being destroyed. As scar tissues gradually spread to entire lung, oxygen uptake is reduced, which causes difficulty in breathing. It is a kind of autoimmune diseases that attacks the patient’s immune system of his or her own tissues. In particular, it is reported that pulmonary fibrosis is frequently found in patients with a severe autoimmune disease.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES